Market closed
$
6.50
Change
+0.35 +5.69%
Volume
Volume 242,392
May 25, 2022, 4:00 p.m.
Quotes are delayed by 20 min
Previous close
$ 6.15
$ 6.50
Change
+0.35 +5.69%
Day low
Day high
$6.01
$6.59

52 week low
52 week high
$5.40
$12.99

Market cap
$166.24M
Average volume
118,326
P/E ratio
N/A
Rev. per Employee
$434,907
EPS
-0.78
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on HROW
-
Imprimis Pharma initiated as buy at B Riley FBR
- Ciara Linnane
-
Express Scripts opts for $1 alternative to Turing’s $750 Daraprim
- Jonathan D. Rockoff
-
Valeant’s use of specialty pharmacy channel is typical of the industry
- Francine McKenna
-
Duckburg Economics: Pricing and Scarcity in Drugs
- Barron's Online
Analyst Ratings
-
More Than 100% Upside Seen In Imprimis After Q4 Results
- Benzinga.com
-
- Benzinga.com
Other News on HROW
-
- Edgar Online - (EDG = 10Q, 10K)
-
- Edgar Online - (EDG = 10Q, 10K)
-
SRK Capital Q4 2021 Investor Letter
- Seeking Alpha
-
Harrow Health: Our 3rd Quarter Update On This Promising Company
- Seeking Alpha
- Loading more headlines...
Press Releases on HROW
-
Harrow Health Announces First Quarter 2022 Financial Results
- BusinessWire - BZX
-
Harrow Health to Announce First Quarter 2022 Financial Results on May 5, 2022
- BusinessWire - BZX
-
Harrow Health Announces Appointments to Its Board of Directors
- BusinessWire - BZX
-
Harrow Health Announces Fourth Quarter and Year-End 2021 Financial Results
- BusinessWire - BZX
-
Harrow Health Announces FDA Acceptance of New Drug Application for AMP-100
- BusinessWire - BZX
-
Harrow Health to Present at Aegis Virtual Conference
- BusinessWire - BZX
-
Harrow Health Publishes Corporate Transparency Report
- BusinessWire - BZX
-
Harrow Health to Participate in H.C. Wainwright BioConnect Conference
- BusinessWire - BZX
-
Melt Pharmaceuticals Submits INDs for MELT‘210 and MELT-400 to FDA
- BusinessWire - BZX
-
Harrow Health Acquires U.S. Commercial Rights to Four Branded Eye Drops
- BusinessWire - BZX
-
Harrow Health Added to the Nasdaq Biotechnology Index
- BusinessWire - BZX
-
Harrow Health Announces Third Quarter 2021 Financial Results
- BusinessWire - BZX
-
Harrow Health to Announce Third Quarter 2021 Financial Results on November 9, 2021
- BusinessWire - BZX
-
Harrow Health Provides $13.5 Million Senior Secured Loan to Melt Pharmaceuticals
- BusinessWire - BZX
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com